MyFinsight
Home
Blog
About
Contact
Download
Download image
Short-term investments
$59,541K
Cash and cash
equivalents
$18,303K
Other current assets
$4,908K
Restricted cash
$110K
Total, at cost
$14,579K
Total current assets
$82,862K
Operating lease
right-of-use assets
$3,089K
Property and equipment,
net
$1,867K
Other assets
$715K
Accumulated depreciation
$12,712K
Total assets
$88,533K
Total liabilities and
stockholders' equity...
$88,533K
Total stockholders'
equity (deficit)
$53,545K
Total liabilities
$34,988K
Accumulated deficit
-$642,201K
Additional paid-in capital
$695,269K
Total current
liabilities
$21,233K
2023 common warrants
liability
$12,183K
Operating lease
liabilities, net of current...
$1,525K
Long term liability
$47K
Accumulated other
comprehensive income
$468K
Common stock, 0.0001
par value...
$9K
Accrued liabilities
$13,526K
Accounts payable
$3,982K
Operating lease
liabilities, current
$3,580K
Finance lease
liabilities, current
$145K
Back
Back
Balance Sheet
source: myfinsight.com
Aligos Therapeutics, Inc. (ALGS)
Aligos Therapeutics, Inc. (ALGS)